Betterlife Pharma Stock Performance
| BETRF Stock | USD 0.08 0.01 9.59% |
The firm shows a Beta (market volatility) of 0.78, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, BetterLife Pharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding BetterLife Pharma is expected to be smaller as well. BetterLife Pharma right now shows a risk of 8.55%. Please confirm BetterLife Pharma maximum drawdown and the relationship between the semi variance and price action indicator , to decide if BetterLife Pharma will be following its price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days BetterLife Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, BetterLife Pharma is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 154.7 K |
BetterLife |
BetterLife Pharma Relative Risk vs. Return Landscape
If you would invest 9.50 in BetterLife Pharma on September 17, 2024 and sell it today you would lose (1.50) from holding BetterLife Pharma or give up 15.79% of portfolio value over 90 days. BetterLife Pharma is currently producing 0.0873% returns and takes up 8.5482% volatility of returns over 90 trading days. Put another way, 76% of traded otc stocks are less volatile than BetterLife, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
BetterLife Pharma Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for BetterLife Pharma's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as BetterLife Pharma, and traders can use it to determine the average amount a BetterLife Pharma's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0102
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | BETRF |
| Negative Returns |
Estimated Market Risk
| 8.55 actual daily | 76 76% of assets are less volatile |
Expected Return
| 0.09 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average BetterLife Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BetterLife Pharma by adding BetterLife Pharma to a well-diversified portfolio.
BetterLife Pharma Fundamentals Growth
BetterLife OTC Stock prices reflect investors' perceptions of the future prospects and financial health of BetterLife Pharma, and BetterLife Pharma fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on BetterLife OTC Stock performance.
| Return On Equity | -44.17 | |||
| Return On Asset | -4.05 | |||
| Current Valuation | 12.42 M | |||
| Shares Outstanding | 90.1 M | |||
| Price To Book | 13.65 X | |||
| EBITDA | (11.92 M) | |||
| Cash And Equivalents | 14.41 K | |||
| Total Debt | 34.56 K | |||
| Debt To Equity | 0.25 % | |||
| Book Value Per Share | (0.12) X | |||
| Cash Flow From Operations | (11.2 M) | |||
| Earnings Per Share | (0.12) X | |||
| Total Asset | 1.16 M | |||
About BetterLife Pharma Performance
By analyzing BetterLife Pharma's fundamental ratios, stakeholders can gain valuable insights into BetterLife Pharma's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if BetterLife Pharma has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if BetterLife Pharma has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
BetterLife Pharma Inc., a biotechnology company, engages in the development and commercialization of compounds for the treatment of neurological disorders in Canada and internationally. BetterLife Pharma Inc. was incorporated in 2002 and is headquartered in Vancouver, Canada. Betterlife Pharma operates under Biotechnology classification in the United States and is traded on OTC Exchange.Things to note about BetterLife Pharma performance evaluation
Checking the ongoing alerts about BetterLife Pharma for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for BetterLife Pharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| BetterLife Pharma had very high historical volatility over the last 90 days | |
| BetterLife Pharma has some characteristics of a very speculative penny stock | |
| BetterLife Pharma has high likelihood to experience some financial distress in the next 2 years | |
| BetterLife Pharma has accumulated 34.56 K in total debt with debt to equity ratio (D/E) of 0.25, which may suggest the company is not taking enough advantage from borrowing. BetterLife Pharma has a current ratio of 0.04, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist BetterLife Pharma until it has trouble settling it off, either with new capital or with free cash flow. So, BetterLife Pharma's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like BetterLife Pharma sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for BetterLife to invest in growth at high rates of return. When we think about BetterLife Pharma's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (12.16 M) with loss before overhead, payroll, taxes, and interest of (22.81 K). | |
| BetterLife Pharma has accumulated about 14.41 K in cash with (11.2 M) of positive cash flow from operations. |
- Analyzing BetterLife Pharma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether BetterLife Pharma's stock is overvalued or undervalued compared to its peers.
- Examining BetterLife Pharma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating BetterLife Pharma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of BetterLife Pharma's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of BetterLife Pharma's otc stock. These opinions can provide insight into BetterLife Pharma's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for BetterLife OTC Stock analysis
When running BetterLife Pharma's price analysis, check to measure BetterLife Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BetterLife Pharma is operating at the current time. Most of BetterLife Pharma's value examination focuses on studying past and present price action to predict the probability of BetterLife Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BetterLife Pharma's price. Additionally, you may evaluate how the addition of BetterLife Pharma to your portfolios can decrease your overall portfolio volatility.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |